SA

Samreen Asif Savkar

Active Director Director DIN 08252923
DIN 08252923 First appointment Oct 2018 Primary industry Manufacturing
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2018
Shareholding value •••• Premium profile

About Samreen Asif Savkar

Data last updated:

Samreen Asif Savkar is a Director at Octogena Pharmaceuticals Private Limited (since 2018). The company operates in Manufacturing. Octogena Pharmaceuticals Private Limited reported revenue of ₹6 Lakh (FY 2025).

DIN 08252923
Primary Designation Director
Industry Manufacturing
First Appointment 09 Oct 2018
Oldest Company Age 8 yrs
Largest company Octogena Pharmaceuticals Private Limited · ₹6 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Oct 20182018₹6 Lakh (FY 2025)Active

Board colleagues of Samreen Asif Savkar

NameDINCompanyDesignation
Asif Savkar08252902Octogena Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Octogena Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Samreen Asif Savkar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Samreen Asif Savkar

Samreen Asif Savkar currently holds 1 directorship: Octogena Pharmaceuticals Private Limited (Director, since 09 Oct 2018, revenue ₹6 Lakh (FY 2025)).

Samreen Asif Savkar was first appointed on 09 Oct 2018 as Director at Octogena Pharmaceuticals Private Limited.

The current boards of Samreen Asif Savkar's companies include Asif Savkar (Octogena Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available